Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection

BACKGROUND: We have constructed and clinically evaluated a hypoallergenic vaccine for grass pollen allergy, BM32, which is based on fusion proteins consisting of peptides from the IgE binding sites of the major grass pollen allergens fused to preS (preS1 + preS2), a domain of the hepatitis B virus (...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:EBioMedicine
Main Authors: Cornelius, Carolin, Schöneweis, Katrin, Georgi, Fanny, Weber, Milena, Niederberger, Verena, Zieglmayer, Petra, Niespodziana, Katarzyna, Trauner, Michael, Hofer, Harald, Urban, Stephan, Valenta, Rudolf
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2016
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5049759/
https://ncbi.nlm.nih.gov/pubmed/27568223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2016.07.023
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares